{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:01:44Z","timestamp":1787666504920,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Advancing fibrosis is regarded as the most important factor when stratifying patients with chronic hepatitis C for retreatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Goals:<\/jats:title>\n                    <jats:p>(1) To compare the performance of 10 biomarkers of fibrosis, including patented tests, among patients with chronic hepatitis C and treatment failure; and (2) to assess the impact on biomarker performance of using 2 different assays of hyaluronic acid (HA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study:<\/jats:title>\n                    <jats:p>For 80 patients, liver histology (Metavir) was compared with biomarker scores using sera obtained within 6 months of liver biopsy (indirect biomarkers: AST:ALT ratio, APRI, Forns index, FIB-4, Fibrometer V3G; direct biomarkers: ELF, Fibrospect II, Hyaluronic acid-HA, Fibrometer V2G, Hepascore). Direct biomarker scores were calculated using 2 validated assays for HA (ELISA and radiometric).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Using the ELISA assay for HA to calculate the direct panels, all 10 of the biomarkers exhibited comparable overall discriminatory performance (unweighted Obuchowski measure, ordROC 0.92-0.94,\n                      <jats:italic toggle=\"yes\">P-<\/jats:italic>\n                      value&gt;0.05) except AST:ALT ratio and APRI (ordROC 0.86-0.88,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      -value&lt;0.05). For the detection of moderate (F2-4) and advanced (F3-4) fibrosis, the AUROC of Fibrometer 2G were significantly higher than AST:ALT ratio and APRI but none of the other biomarkers. Good correlation was observed between the 2 HA assays (intraclass correlation coefficient=0.873) with the ELISA assay exhibiting superior diagnostic performance (ordROC 0.92 vs. 0.88,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      -value=0.003). Importantly, the performance of many of the direct biomarkers at their diagnostic thresholds was heavily influenced by the choice of HA assay.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Although many biomarkers exhibited good diagnostic performance for the detection of advancing fibrosis, our results indicate that diagnostic performance may be significantly affected by the selection of individual component assays.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mcg.0000000000000581","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T07:18:56Z","timestamp":1467616736000},"page":"268-277","source":"Crossref","is-referenced-by-count":20,"title":["Biomarkers of Hepatic Fibrosis in Chronic Hepatitis C"],"prefix":"10.1097","volume":"51","author":[{"given":"Sudeep","family":"Tanwar","sequence":"first","affiliation":[{"name":"Institute for Liver & Digestive Health, University College London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Trembling","sequence":"additional","affiliation":[{"name":"Institute for Liver & Digestive Health, University College London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Hogan","sequence":"additional","affiliation":[{"name":"Institute for Liver & Digestive Health, University College London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Parkes","sequence":"additional","affiliation":[{"name":"Public Health Sciences and Medical Statistics, University of Southampton, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Harris","sequence":"additional","affiliation":[{"name":"Public Health Sciences and Medical Statistics, University of Southampton, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Grant","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Virology, University College London Hospitals NHS Foundation Trust, London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Nastouli","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Virology, University College London Hospitals NHS Foundation Trust, London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Ocker","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University of Erlangen, Erlangen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Wehr","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University of Erlangen, Erlangen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Herold","sequence":"additional","affiliation":[{"name":"Department of Medicine 1, University of Erlangen, Erlangen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Neureiter","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Paracelsus Medical University\/Salzburger Landeskliniken (SALK), Muellner Hauptstrasse 48, 5020 Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[{"name":"Institute of Molecular and Translational Medicine"},{"name":"Department of Medicine"},{"name":"Research Center for Immunology (FZI), University of Mainz, Mainz, Germany"},{"name":"Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Institute for Liver & Digestive Health, University College London"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230913","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2012.12.007","article-title":"Hepatitis C infection and presence of advanced fibrosis: wait or treat? Why wait? There is no time to lose, is there?","volume":"58","author":"Tillmann","year":"2013","journal-title":"J Hepatol"},{"key":"R2-20230913","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"R3-20230913","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R4-20230913","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"R5-20230913","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7326\/0003-4819-158-11-201306040-00005","article-title":"Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review","volume":"158","author":"Chou","year":"2013","journal-title":"Ann Intern Med"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1056\/NEJM197810262991705","article-title":"Problems of spectrum and bias in evaluating the efficacy of diagnostic tests","volume":"299","author":"Ransohoff","year":"1978","journal-title":"N Engl J Med"},{"key":"R8-20230913","doi-asserted-by":"crossref","first-page":"P4_07","DOI":"10.1055\/s-2008-1037602","article-title":"The combination of silymarin and pegylated interferon alpha2b attenuates the progression of liver fibrosis in prior nonresponders and relapsers with chronic hepatitis C infection - the PROFI C trial","volume":"46","author":"Ocker","year":"2008","journal-title":"Z Gastroenterol"},{"key":"R9-20230913","first-page":"505","article-title":"A rapid Mallory trichrome stain (chromotrope-aniline blue)","volume":"62","author":"Churg","year":"1956","journal-title":"AMA Arch Pathol"},{"key":"R10-20230913","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.24711","article-title":"Induction of heme oxygenase 1 prevents progression of liver fibrosis in Mdr2 knockout mice","volume":"55","author":"Barikbin","year":"2012","journal-title":"Hepatology"},{"key":"R11-20230913","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"R12-20230913","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1572-0241.1998.044_c.x","article-title":"AST\/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection","volume":"93","author":"Sheth","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"R13-20230913","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00004836-200607000-00013","article-title":"APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C","volume":"40","author":"Snyder","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"R14-20230913","first-page":"986","article-title":"Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model","volume":"36","author":"Forns","year":"2002","journal-title":"Hepatology"},{"key":"R15-20230913","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"R16-20230913","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-230X-11-132","article-title":"Comparison of accuracy of fibrosis degree classifications by liver biopsy and non-invasive tests in chronic hepatitis C","volume":"11","author":"Boursier","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1373\/clinchem.2005.048389","article-title":"Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection","volume":"51","author":"Adams","year":"2005","journal-title":"Clin Chem"},{"key":"R18-20230913","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2010.03.007","article-title":"Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV\/HCV co-infection","volume":"53","author":"Cales","year":"2010","journal-title":"J Hepatol"},{"key":"R19-20230913","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: a cohort study","volume":"127","author":"Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"key":"R20-20230913","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jhep.2004.08.008","article-title":"Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients","volume":"41","author":"Patel","year":"2004","journal-title":"J Hepatol"},{"key":"R21-20230913","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1440-1746.2000.02233.x","article-title":"Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group","volume":"15","author":"McHutchison","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"R22-20230913","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jhep.2006.12.013","article-title":"Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C","volume":"46","author":"Leroy","year":"2007","journal-title":"J Hepatol"},{"key":"R24-20230913","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/sim.2228","article-title":"An ROC-type measure of diagnostic accuracy when the gold standard is continuous-scale","volume":"25","author":"Obuchowski","year":"2006","journal-title":"Stat Med"},{"key":"R25-20230913","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"R26-20230913","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.clinbiochem.2008.06.020","article-title":"Diagnostic accuracy, reproducibility and robustness of fibrosis blood tests in chronic hepatitis C: a meta-analysis with individual data","volume":"41","author":"Leroy","year":"2008","journal-title":"Clin Biochem"},{"key":"R27-20230913","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cca.2010.11.009","article-title":"Assessment of new hyaluronic acid assays and their impact on FibroMeter scores","volume":"412","author":"Veillon","year":"2011","journal-title":"Clin Chim Acta"},{"key":"R28-20230913","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clinbiochem.2007.08.009","article-title":"Reproducibility of blood tests of liver fibrosis in clinical practice","volume":"41","author":"Cales","year":"2008","journal-title":"Clin Biochem"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004836-201703000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:16:19Z","timestamp":1694625379000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-201703000-00015"}},"subtitle":["A Comparison of 10 Biomarkers Using 2 Different Assays for Hyaluronic Acid"],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0000000000000581","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726485632.793520769","asserted-by":"object"}]},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}